home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

4th Protein Discovery & Therapeutics

 
  July 11, 2011  
     
 
GTC Conference, Paradise Point Resort & Spa, San Diego, CA
Oct 19-21, 2011


Tentative Sessions:
The Future of Protein Discovery
• The Future of Protein Discovery
• Bi-specific and Multi-specific
• Modified Antibodies
• Antibody Conjugates
• Biosimilars and Biosuperiors
Novel Alternative Protein Therapeutics
• Non-IG Scaffolds
• Antibody Fragments
• New Peptide Approachs
• Nutraceuticals
Overcoming Challenges in Protein Therapeutics
• Immunogenicity
• Stability
• Delivery Systems
• Extending half-life
• Nanoparticles
 
 
Organized by: GTC Conference
Invited Speakers:
DISTINGUISHED ADVISORY BOARD
 
Chris Bebbington
Vice President, Research
KalosBio
 
Partha Chowdhury
Principal Scientist, Antibody Discovery and Protein Engineering
MedImmune
 
Ed Croze
Director, Translational Research
Bayer Healthcare Pharmaceuticals
 
Dimiter Dimitrov
Head, Protein Interaction Group
NCI, NIH
 
Nicolas Fischer
Head, Research
NovImmune SA
 
Patricia Grasso
Associate Professor, Medicine
Albany Medical Center
 
Roman Kischel
Director, Immunotherapy
Micromet AG
 
William McDonald
Group Leader, Protein Sciences
Pfizer
 
Anwar Murtaza
Senior Scientist
Abbott
 
Terrence Town
Endowed Chair in Regenerative Medicine, Maxine Dunitz Neurosurgical Institute
Cedars-Sinai Medical Center
 
Josh Xiao
Principal Scientist, Oncology Discovery
Amgen
 
Deadline for Abstracts: Sept. 19,2011
 
Registration: https://www.gtcbio.com/component/register/?cn=4th+Protein+Discovery+Therapeutics&cid=44
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.